Reported 2 months ago
Tilray's CEO, Irwin Simon, emphasizes that the company should not be viewed solely as a cannabis provider but as a consumer packaged goods company. Despite reporting a narrower loss of $0.01 per share on revenues of $200 million, below expectations, Simon highlights significant growth in both the cannabis and alcoholic beverage sectors, including a 139% increase due to a recent Molson Coors partnership. He asserts that Tilray's strategy is to focus on annual growth and diversification, boasting a broad portfolio of 44 brands and positioning itself strongly in both the U.S. craft brewing and European medical cannabis markets.
Source: YAHOO